Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results (47)

« Back to Publications

Table 1 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms

Larkin JR. et al, (2025)

Data from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms

Larkin JR. et al, (2025)

Figure 1 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms

Larkin JR. et al, (2025)

Figure 2 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms

Larkin JR. et al, (2025)

Figure 4 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms

Larkin JR. et al, (2025)

Figure 5 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms

Larkin JR. et al, (2025)

Figure 3 from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms

Larkin JR. et al, (2025)

Patient characteristics, serious disease diagnoses, and incidental findings in individuals with non-specific symptoms referred to the Suspected CANcer (SCAN) Pathway: a prospective cohort study in England

Friedemann Smith C. et al, (2025), The Lancet Primary Care, 1, 100019 - 100019

Cancer inequalities in the United Kingdom and the data used to measure them: a scoping review

Underwood S. et al, (2025), The Lancet Regional Health - Europe, 52

Characteristics of Optimal Cancer Referrals Made by Primary Care Clinicians: Scoping Review

Olakotan O. et al, (2025), Cancer Control, 32

Clinical Prediction Models Incorporating Blood Test Trend for Cancer Detection: Systematic Review, Meta-Analysis, and Critical Appraisal

Virdee PS. et al, (2025), Jmir Cancer, 11

manifesto for improving cancer detection: four key considerations when implementing innovations across the interface of primary and secondary care

Dowrick A. et al, (2024), The Lancet Oncology, 25, e388 - e395

The Association between Blood Test Trends and Undiagnosed Cancer: A Systematic Review and Critical Appraisal

Virdee PS. et al, (2024), Cancers, 16

dequacy of clinical guideline recommendations for patients with low-risk cancer managed with monitoring: systematic review

Collins KK. et al, (2024), Journal of Clinical Epidemiology, 169

Supplementary Data from Metabolomic Biomarkers in Blood Samples Identify Cancers in a Mixed Population of Patients with Nonspecific Symptoms

Larkin JR. et al, (2023)

Load More